Skip to content

Clinical trials

Terminated Hepatitis B trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B Status: Terminated Clear all

56 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20034
20042
20052
20062
20076
20084
20093
20123
20143
20155
20163
20171
20184
20194
20202
20212
20222
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated56

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Arrowhead Pharmaceuticals6
Bukwang Pharmaceutical6
GlaxoSmithKline4
Assembly Biosciences3
F-star Therapeutics, Inc.3
French National Agency for Research on AIDS and Viral Hepatitis2
Gilead Sciences2
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2
Novartis2
Pharmasset2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B56
Hepatitis B, Chronic16
Hepatitis C7
Carcinoma, Hepatocellular3
Hepatitis3
Non-alcoholic Fatty Liver Disease3
Diphtheria2
Fibrosis2
Haemophilus Infections2
Hepatitis, Chronic2

Trials

Showing 26 to 50 of 56. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.